ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38643 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38643; 2) Community: the network communities that were significantly associated with the response to NSC 38643; 3) Molecule: the relationships between components within communities and NSC 38643; 4) MDR: the compounds that were significantly associated with the NSC 38643.

NSC Compound Enrichment Correlation
NSC 711745 Null 0.0244632509325736 0.53513201
NSC 712734 Null 0.0244632509325736 -0.11867472
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0244632509325736 0.48370839
NSC 736914 Null 0.0244632509325736 0.36035107
NSC 740276 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide 0.0244632509325736 0.30631165
NSC 747452 3,19-(4-Acetamido)benzylidineandrographolide 0.0244632509325736 0.25281294
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0244718705444135 0.67537809
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0244718705444135 0.68949163
NSC 671891 Null 0.0244718705444135 0.5876653
NSC 698148 Null 0.0244718705444135 0.14604019
Total:101  Current:60    [First] [Prev] [Next] [Last]